Patents
Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
02/2008
02/12/2008US7329750 17-Acetamido-4-azasteroid derivatives as androgen receptor modulators
02/12/2008US7329676 2-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors
02/12/2008US7329673 selective agonists of (MC-4R); obesity, diabetes, male and female sexual dysfunction, insulin resistance, osteoartritis; long duration of action, side effects reduction; stereoisomers
02/07/2008WO2008016166A1 Fused heterocyclic compound and organic light emitting device
02/07/2008US20080033013 Pyrazolylphenyl and pyrrolylphenyl inhibitors of lta4h for treating inflammation
02/06/2008CN101119971A Cyclohepta[b]pyridine-3-carbonylguanidine derivative and pharmaceutical product containing same
02/06/2008CN100366622C 20(S) camptotheca alkaloid derivatives, their preparing methods and uses
02/06/2008CN100366621C Plumepoppy total alkaloid salt and its prepn and application
02/06/2008CN100366620C Process for the preparation of 4-(8-chloro-5,6-dihydro-11h-benzo(5,6)-cyclohepta-(1,2b)-pyridin-11-ylidene)-1-piperidinecarboxyli c acid ethyl ester (loratadine)
02/05/2008US7326789 E.g., 2-(4-Chloro-phenylsufonylamino)-4,5-dimethoxy-N-(4-(thiomorpholine-4-sulfonyl)-phenyl)-benzamide; cardiovascular disorders; hypotensive agents; angina pectoris, cardiac insufficiency, thrombolytic agents; atherosclerosis; activating soluble guanylate cyclase to adjust a disturbed cyclic GMP balance
01/2008
01/31/2008US20080027228 Substituted thioacetamides
01/31/2008US20080027109 bis-[2-(pivaloylamino)phenyl]disulfide; cholesteryl ester transfer protein (CETP); atherosclerosis, hyperlipidemia
01/31/2008US20080027097 Pharmaceutical drug candidates and methods for preparation thereof
01/31/2008US20080027090 N-5,6,9,10,11,12-hexahydro-4H,8H-cyclohepta[4,5]pyrrolo[3,2,1-ij]quinolin-2-yl-3,3-dimethylbutanamide; for treating cardiovascular disorders, nervous system disorders e.g epilepsy, episodic ataxia type 1, paroxysmal dyskinesia, neurodegenerative spincerebrallar ataxia, Parkinson's disease
01/31/2008US20080027040 Oxazolidinone-Quinolone Hybrid Antibiotics
01/31/2008US20080027036 S1P receptor modulating compounds and use thereof
01/31/2008US20080026407 Covalent tethering of functional groups to proteins
01/30/2008EP1521757B1 tricyclic spiropiperidines or spiropyrrolidines
01/30/2008CN101115734A Spiro derivatives as lipoxygenase inhibitors
01/30/2008CN101115719A Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives
01/30/2008CN100364536C Desoxyribose nucleic acid dual intercalating agent using methyl iso thiourea cation as linker
01/29/2008US7323566 Apomorphine derivatives; radioimaging agents upon incorporation of radionuclides; neuronal function diagnosis
01/29/2008US7323475 Adjust concentration of erythropoietin in blood; strokes; antiepileptic agents; liver disorders; antiulcer agents; central nervous system disorders
01/24/2008WO2008010481A1 Aminoindan derivative or salt thereof
01/24/2008WO2008010073A1 Tartrate salt of (7s)-7-[(5-fluoro-2-methyl-benzyl)oxy]-2-[(2r)-2-methylpiperazin-1-yl]-6,7-dihydro-5h-cyclopenta[b]pyridine
01/24/2008WO2008009881A1 Chemical compounds
01/24/2008US20080021220 Naphthalene-based semiconductor materials and methods of preparing and use thereof
01/24/2008US20080021058 Pyrazolo '3,4-B! Pyridine Compounds And Their Use As Phosphodiesterase Type 4(Pde4) Inhibitors
01/24/2008US20080021057 3-Trifluoromethyl,6-((3-(methyl,4-hydroxytetrahydropyran-4-yl)-amino-(3-isopropyl-cyclopent-1,3-ylene))-carbonyl-)-5,6,7,8-tetrahydro-1,6-naphthyridine; antiinflammatory agents; immunomodulators; antiallergens; rhintis; dermatitis; conjunctivits, asthma; autoimmune diseases; antiarthritis agents
01/24/2008US20080021038 Novel Piperidine/8-Azabicyclo [3.2.1.] Octan Derivatives As Modulators Of Chemokine Receptor Ccr5
01/24/2008US20080021034 Compositions and methods for modulating gated ion channels
01/24/2008US20080021012 3-[4-{6-Substituted Alkanoyl Pyridin-3-Yl}-3-Phenyl]-5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones As Antibacterial Agents
01/24/2008CA2657640A1 Tartrate salt of (7s)-7-[(5-fluoro-2-methyl-benzyl)oxy]-2-[(2r)-2-methylpiperazin-1-yl]-6,7-dihydro-5h-cyclopenta[b]pyridine
01/23/2008EP1880996A1 Spiroindolinepiperidine derivatives
01/23/2008EP1879847A1 Terrylene and quaterrylene derivatives
01/23/2008EP1268425B1 Carbamate caspase inhibitors and uses thereof
01/23/2008CN101111482A Luminescent indicator dye and optical sensor
01/23/2008CN101108826A Method for normal-temperature high-pressure aconine extracting and formulated product thereof
01/23/2008CN101108825A Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists
01/23/2008CN100363366C Camptothecin derviative and preparation process thereof
01/23/2008CN100363350C Process for the preparation of aryl fused polycyclic lactams
01/17/2008WO2008006454A1 Electroluminescent polymers and use thereof
01/17/2008WO2008006286A1 ANALGESIC 5, 9 - METHANOCYCLOOCTA (b) PYRIDIN - 2 (1H) - ONE DERIVATIVES, THEIR PREPARATION METHOD AND USE
01/17/2008WO2007005534A8 Chemical compounds
01/17/2008US20080015276 7.9 diethyl-6,7,9-trimethyl-8-(1-phenyl-ethoxy)-1,4-dioxa-8-aza-spiro[4.5]decane initiator for polymerizing ethylenically unsaturated monomer(s); low polydispersity
01/17/2008US20080015213 Macrocyclic Aminopyridyl Beta-Secretase Inhibitors For The Treatment Of Alzheimer's Disease
01/17/2008US20080015172 Caspase inhibitors and uses thereof
01/17/2008CA2635903A1 Bisnaphthalimidopropyl derivative compounds with anti-parasite and anti-cancer activity
01/15/2008US7318966 Luminescent element material and luminescent element comprising the same
01/10/2008WO2008005910A2 Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors
01/10/2008WO2008005295A2 Modulators of muscarinic receptors
01/10/2008US20080009630 Photogenerated reagents
01/10/2008US20080009489 Androgen receptor modulators and method of treating disease using the same
01/10/2008US20080009486 6-chloro-2'-(3-chlorophenyl)-4'-(2,2-dimethylpropyl)spiro[3H-indole-3,3'-piperidine]-2,6'(1H)-dione; mdm2 antagonists; have effects in p53 mutant cells by mdm2-p53 feedback control loop; anticarcinogenic agent;
01/10/2008US20080009450 Genipin derivatives and uses thereof
01/10/2008US20080008930 Ionic Liquid
01/10/2008CA2656183A1 Modulators of muscarinic receptors
01/09/2008EP1874773A1 Hexarylene and pentarylene tetracarboxylic acid diimides
01/09/2008EP1874731A2 Quinobenzoxazine analogs and methods of using thereof
01/09/2008EP1874310A2 Opioid receptor agonist compounds and their use in treatment of pain
01/09/2008EP1176956B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
01/09/2008CN101100455A 5,9-methylenecyclooctyl(b)pyridin-2(1H)-one derivative with ease pain action and its preparation and application
01/09/2008CN100360129C Dehydro eleagnine derivative, its synthesizing method and use
01/08/2008CA2394027C New derivatives of octahydro-2h-pyrido[1,2-a] pyrazine, their preparation process and pharmaceutical compositions that contain them
01/03/2008US20080004315 Guanidine Derivatives and Therapeutic Uses Thereof
01/03/2008US20080004263 Ligands of Follicle Stimulating Hormone Receptor and Methods of Use Thereof
01/03/2008US20080004262 2,2,7,9-tetramethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-pyrano[2,3-g]quinolin-3-ol; 3-hydroxy-2,2,9-trimethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-pyrano[2,3-g]quinolin-7-carbonitrile; have the prolongation effect on refractory period
01/03/2008US20080004261 Calcitonin Gene-Related Peptide (CGRP); headaches, pain, hot flashes; compounds are based on 3-substituted-5-(piperidinocarbonylmethyl)-thiazolidin-4-one moiety and ring derivatives thereof
01/03/2008US20080004258 such as [2-(3,4-Dichloro-phenoxy)-5-(4-morpholin-4-yl-but-1-ynyl)-benzyl]-methyl-amine, used as H3 receptor and/or serotonin transporter modulators useful in the treatment of cognitive, sleep and psychological disorders
01/03/2008US20080004248 prostate cancer, benign prostatic hyperplasia, acne, seborrhea, hirsutism, androgenic alopecia, precocious puberty, adrenal hyperlasia and polycystic ovarian syndrome, breast cancer, endometriosis, leiomyoma and precocious puberty, estrogen dependent diseases
01/02/2008EP1871761A2 Spirocyclic heterocyclic derivatives and methods of their use
01/02/2008CN101098856A Lactam compounds and their use as pharmaceuticals
01/02/2008CN101098852A Glycogen phosphorylase inhibitor compounds and pharmaceutical compositions thereof
01/02/2008CN101096358A Method for synthesizing nucleus medical imaging agent ligand
01/02/2008CN100358869C Carbamate caspase inhibitors and uses thereof
12/2007
12/27/2007WO2007147775A1 Process for synthesis of aromatic compounds
12/27/2007US20070299111 Benzamide derivatives and uses related thereto
12/27/2007US20070299109 Dimeric Compounds Of Piperidine, Piperazine Or Morpholine Or Their 7-Membered Analogs Suitable For The Treatment Of Neurodegenerative Disorders
12/27/2007US20070299102 Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer
12/27/2007US20070299100 Analgesic
12/27/2007US20070299077 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
12/27/2007US20070299073 Imidazolyl derivatives
12/27/2007US20070299052 Inhibitors of IAP
12/26/2007EP1869000A1 Cyclopentapyridine and tetrahydroquinoline derivatives
12/26/2007CN101094838A Tubulin binding anticancer agents and prodrugs thereof
12/26/2007CN101092397A Structure modified compound of sinomenine, and prepartion method
12/26/2007CN101092396A Method for preparing template compound of ancylus fluviatilis [1,3 dihydro indene ¿C 4í»- piperidine 1 - carboxylic acid]
12/26/2007CN101092395A Method for preparing derivative of 1,4 ¿C dichloro isoquinoline category
12/26/2007CN100357326C Method for producing aqueous polymer dispersions containing colorants
12/25/2007US7312228 Cytotoxic indeno and isoindoloisoquinolones
12/21/2007WO2007144200A1 Process for the covalent coupling of two molecules by means of a diels-alder reaction with inverse electron requirement
12/21/2007WO2007120263A3 Preparation of dutasteride
12/20/2007US20070293681 reacting aromatic imine derivatives with hydrogen in presence of a base ( potassium-tert-butoxide) and a hydrogenation catalytic system comprises a ruthenium complex containing a diamine and a diphosphine ligand or monodentate phosphine ligand to produce an aromatic amine derivatives
12/20/2007US20070293531 Muscarinic Acetycholine Receptor Antagonists
12/20/2007US20070290199 copolymers comprising rare earth metal complexes; light-emitting devices; improved semi-conductive properties and/or mechanical flexibility
12/19/2007EP1867638A1 Procedure for the Conection of two Molecules via Diels-Alder Reactions with Inverse Electron Demand
12/19/2007EP1865956A2 Piperidinyl substituted cyclohexane-1,4-diamines
12/19/2007EP1664031B1 Adamantane and azabicyclo-octane and nonane derivatives process of their preparation and their use as dpp-iv inhibitors
12/19/2007EP1032556B1 Pharmaceutically active compounds and methods of use
12/19/2007CN101090891A Methods for treating diseases with 4-hydroxybenzomorphans
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 110